Article
MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma
9 Mar 2022
Abstract excerpt
Bladder urothelial carcinoma (BLC) is one of the most common cancers in men, and its heterogeneity challenges the treatment to cure this disease. Recently, microRNAs (miRNAs) gained promising attention as biomarkers due to their potential roles in cancer biology. Identifying survival-associated miRNAs may help identify targets for therapeutic interventions in BLC. This work aims to identify a miRNA signature that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
